Genes, cognition and brain through a COMT lens

Neuroscience

Volumn 164, Issue 1, 2009, Pages 72-87

  Dickinson, D ^a,b   Elvevag B ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Executive function; Prefrontal cortex; Working memory

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ANIMAL; BRAIN; COGNITION; EMOTION; ENVIRONMENT; GENETICS; HUMAN; METABOLISM; PHENOTYPE; PHYSIOLOGY; PREFRONTAL CORTEX; REVIEW;

ANIMALS; BRAIN; CATECHOL O-METHYLTRANSFERASE; COGNITION; EMOTIONS; ENVIRONMENT; HUMANS; PHENOTYPE; PREFRONTAL CORTEX;

EID: 74049110540     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.05.014     Document Type: Review

References (129)

1. Aguilera M., Barrantes-Vidal N., Arias B., Moya J., Villa H., Ibáñez M.I., et al. Putative role of the COMT gene polymorphism (Val158Met) on verbal working memory functioning in a healthy population. Am J Med Genet B Neuropsychiatr Genet 2008, 147B(6):898-902.
2. Apud J.A., Weinberger D.R. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors. CNS Drugs 2007, 21:535-557.
3. Arseneault L., Cannon M., Witton J., Murray R.M. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004, 184:110-117.
4. Awh E., Jonides J., Reuter-Lorenz P.A. Rehearsal in spatial working memory. J Exp Psychol Hum Percept Perform 1998, 24:780-790.
5. Bachevalier J., Mishkin M. Visual recognition impairment follows ventromedial but not dorsolateral prefrontal lesions in monkeys. Behav Brain Res 1986, 20:249-261.
6. Bäckman L., Nyberg L., Lindenberger U., Li S.C., Farde L. The correlative triad among aging dopamine, and cognition: current status and future prospects. Neurosci Biobehav Rev 2006, 30:791-807.
7. Baddeley A. Working memory. Science 1992, 255:556-559.
8. Barch D.M., Carter C.S. Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: a report of the second consensus building conference of the CNTRICS initiative. Schizophr Bull 2008, 34:613-618.
9. Barch D.M., Smith E. The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia. Biol Psychiatry 2008, 64:11-17.
10. Barnett J.H., Jones P.B., Robbins T.W., Müller U. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry 2007, 12:502-509.
11. Barnett J.H., Scoriels L., Munafo M.R. Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry 2008, 64:137-144.
12. Bellgrove M.A., Hawi Z., Kirley A., Gill M., Robertson I.H. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype. Neuropsychologia 2005, 43:1847-1857.
13. Berg E.A. A simple objective technique for measuring flexibility in thinking. J Gen Psychol 1948, 39:15-22.
14. Bertolino A., Caforio G., Blasi G., De Candia M., Latorre V., Petruzzella V., et al. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry 2004, 161:1798-1805.
15. Bertolino A., Rubino V., Sambataro F., Blasi G., Latorre V., Fazio L., et al. Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype. Biol Psychiatry 2006, 60:1250-1258.
16. Bialecka M., Kurzawski M., Klodowska-Duda G., Opala G., Tan E.K., Drozdzik M. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease levodopa treatment response, and complications. Pharmacogenet Genomics 2008, 18:815-821.
17. Bilder R.M., Volavka J., Czobor P., Malhotra A.K., Kennedy J.L., Ni X., et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 2002, 52:701-707.
18. Bilder R.M., Volavka J., Lachman H.M., Grace A.A. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 2004, 29:1943-1961.
19. Blasi G., Mattay V.S., Bertolino A., Elvevåg B., Callicott J.H., Das S., et al. Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci 2005, 25:5038-5045.
20. Bruder G.E., Keilp J.G., Xu H., Shikhman M., Schori E., Gorman J.M., et al. Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol Psychiatry 2005, 58:901-907.
21. Callicott J.H., Mattay V.S., Bertolino A., Finn K., Coppola R., Frank J.A., et al. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 1999, 9:20-26.
22. Carter C.S., Perlstein W., Ganguli R., Brar J., Mintun M., Cohen J.D. Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 1998, 155:1285-1287.
23. Caspi A., Moffitt T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 2006, 7:583-590.
24. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biol Psychiatry 2005, 57:1117-1127.
25. Caspi A., Williams B., Kim-Cohen J., Craig I.W., Milne B.J., Poulton R., et al. Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proc Natl Acad Sci U S A 2007, 104:18860-18865.
26. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004, 75:807-821.
27. Cheuk D.K., Wong V. Meta-analysis of association between a catechol-O-methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behav Genet 2006, 36:651-659.
28. Daniel D.G., Weinberger D.R., Jones D.W., Zigun J.R., Coppola R., Handel S., et al. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 1991, 11:1907-1917.
29. de Frias C.M., Annerbrink K., Westberg L., Eriksson E., Adolfsson R., Nilsson L.G. COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav Genet 2004, 34:533-539.
30. Diamond A., Briand L., Fossella J., Gehlbach L. Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry 2004, 161:125-132.
31. Diaz-Asper C.M., Goldberg T.E., Kolachana B.S., Straub R.E., Egan M.F., Weinberger D.R. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients their siblings, and healthy controls. Biol Psychiatry 2008, 63:72-79.
32. Drabant E.M., Hariri A.R., Meyer-Lindenberg A., Muñoz K.E., Mattay V.S., Kolachana B.S., et al. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry 2006, 63:1396-1406.
33. Durstewitz D., Seamans J.K. The computational role of dopamine D1 receptors in working memory. Neural Netw 2002, 15:561-572.
34. Durstewitz D., Seamans J.K., Sejnowski T.J. Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. J Neurophysiol 2000, 83:1733-1750.
35. Eerola J., Launes J., Hellstrom O., Tienari P.J. Apolipoprotein E (APOE) PARKIN and catechol-O-methyltransferase (COMT) genes and susceptibility to sporadic Parkinson's disease in Finland. Neurosci Lett 2002, 330:296-298.
36. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001, 98:6917-6922.
37. Egan M.F., Straub R.E., Goldberg T.E., Yakub I., Callicott J.H., Hariri A.R., et al. Variation in GRM3 affects cognition prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A 2004, 101:12604-12609.
38. Eley T.C., Tahir E., Angleitner A., Harriss K., McClay J., Plomin R., et al. Association analysis of MAOA and COMT with neuroticism assessed by peers. Am J Med Genet B Neuropsychiatr Genet 2003, 120B:90-96.
39. Ettinger U., Kumari V., Collier D.A., Powell J., Luzi S., Michel T.M., et al. Catechol-O-methyltransferase (COMT) Val(158)Met genotype is associated with BOLD response as a function of task characteristic. Neuropsychopharmacology 2008, 33:3046-3057.
40. Fan J., Hof P.R., Guise K.G., Fossella J.A., Posner M.I. The functional integration of the anterior cingulate cortex during conflict processing. Cereb Cortex 2008, 18:796-805.
41. Foltynie T., Goldberg T.E., Lewis S.G., Blackwell A.D., Kolachana B.S., Weinberger D.R., et al. Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism. Mov Disord 2004, 19:885-891.
42. Frank M.J., Claus E.D. Anatomy of a decision: striato-orbitofrontal interactions in reinforcement learning, decision making, and reversal. Psychol Rev 2006, 113:300-326.
43. Frank M.J., Moustafa A.A., Haughey H.M., Curran T., Hutchison K.E. Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. Proc Natl Acad Sci U S A 2007, 104:16311-16316.
44. Fuster J.M. Network memory. Trends Neurosci 1997, 20:451-459.
45. Goldberg T.E., Egan M.F., Gscheidle T., Coppola R., Weickert T., Kolachana B.S., et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 2003, 60:889-896.
46. Goldberg T.E., Weinberger D.R. Genes and the parsing of cognitive processes. Trends Cogn Sci 2004, 8:325-335.
47. Goldman-Rakic P.S. The cortical dopamine system: role in memory and cognition. Adv Pharmacol 1998, 42:707-711.
48. Gothelf D., Eliez S., Thompson T., Hinard C., Penniman L., Feinstein C., et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q112 deletion syndrome. Nat Neurosci 2005, 8:1500-1502.
49. Green A.E., Munafo M.R., Deyoung C.G., Fossella J.A., Fan J., Gray J.R. Using genetic data in cognitive neuroscience: from growing pains to genuine insights. Nat Rev Neurosci 2008, 9:710-720.
50. Halleland H., Lundervold A.J., Halmøy A., Haavik J., Johansson S. Association between catechol O-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in adults. Am J Med Genet B Neuropsychiatr Genet 2008, 150B:403-410.
51. Hariri A.R., Weinberger D.R. Imaging genomics. Br Med Bull 2003, 65:259-270.
52. Harrison P.J., Tunbridge E.M. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 2007, in press.
53. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005, 10:40-68. image 45.
54. Henquet C., Rosa A., Delespaul P., Papiol S., Fananás L., van Os J., et al. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of "switching on" hallucinations in the flow of daily life. Acta Psychiatr Scand 2009, 119:156-160.
55. Henquet C., Rosa A., Krabbendam L., Papiol S., Fananás L., Drukker M., et al. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 2006, 31:2748-2757.
56. Ho B.C., Wassink T.H., O'Leary D.S., Sheffield V.C., Andreasen N.C. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry 2005, 10:229. 287-298.
57. Jonides J., Schumacher E.H., Smith E.E., Koeppe R.A., Awh E., Reuter-Lorenz P.A., et al. The role of parietal cortex in verbal working memory. J Neurosci 1998, 18:5026-5034.
58. Karoum F., Chrapusta S.J., Egan M.F. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex nucleus accumbens, and striatum by a simple two pool model. J Neurochem 1994, 63:972-979.
59. Kereszturi E., Tarnok Z., Bognar E., Lakatos K., Farkas L., Gadoros J., et al. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1431-1435.
60. Krabbendam L., Isusi P., Galdos P., Echevarria E., Bilbao J.R., Martin-Pagola A., et al. Associations between COMTVal158Met polymorphism and cognition: direct or indirect effects?. Eur Psychiatry 2006, 21:338-342.
61. Kremen W.S., Eisen S.A., Tsuang M.T., Lyons M.J. Is the Wisconsin Card Sorting Test a useful neurocognitive endophenotype?. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:403-406.
62. Lang U.E., Bajbouj M., Sander T., Gallinat J. Gender-dependent association of the functional catechol-O-methyltransferase Val158Met genotype with sensation seeking personality trait. Neuropsychopharmacology 2007, 32:1950-1955.
63. Levy R., Goldman-Rakic P.S. Segregation of working memory functions within the dorsolateral prefrontal cortex. Exp Brain Res 2000, 133:23-32.
64. Li S-C Lindenberger U, Chicherio C, von Oertzen T, Nagel I, Gaus V, et al. (In press) COMT genotype affects processing fluctuation and evidence accumulation in perceptual decision-making. In press.
65. Logothetis N.K., Pauls J., Augath M., Trinath T., Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature 2001, 412:150-157.
66. MacDonald S.W., Nyberg L., Bäckman L. Intra-individual variability in behavior: links to brain structure neurotransmission and neuronal activity. Trends Neurosci 2006, 29:474-480.
67. Malhotra A.K., Kestler L.J., Mazzanti C., Bates J.A., Goldberg T., Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002, 159:652-654.
68. Mattay V.S., Berman K.F., Ostrem J.L., Esposito G., Van Horn J.D., Bigelow L.B., et al. Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study. J Neurosci 1996, 16:4816-4822.
69. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 2003, 100:6186-6191.
70. Meyer-Lindenberg A., Nichols T., Callicott J.H., Ding J., Kolachana B., Buckholtz J., et al. Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry 2006, 11:797. 867-877.
71. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006, 7:818-827.
72. Mishkin M., Manning F.J. Non-spatial memory after selective prefrontal lesions in monkeys. Brain Res 1978, 143:313-323.
73. Miyake A., Friedman N.P., Emerson M.J., Witzki A.H., Howerter A., Wager T.D. The unity and diversity of executive functions and their contributions to complex "frontal lobe" tasks: a latent variable analysis. Cogn Psychol 2000, 41:49-100.
74. Montag C., Buckholtz J.W., Hartmann P., Merz M., Burk C., Hennig J., et al. COMT genetic variation affects fear processing: psychophysiological evidence. Behav Neurosci 2008, 122:901-909.
75. Mukherjee N., Kidd K.K., Pakstis A.J., Speed W.C., Li H., Tarnok Z., et al. The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase. Mol Psychiatry 2008, in press.
76. Nackley A.G., Shabalina S.A., Tchivileva I.E., Satterfield K., Korchynskyi O., Makarov S.S., Maixner W., et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006, 314(5807):1930-1933.
77. Naftolin F., Malaspina D. Estrogen, estrogen treatment and the post-reproductive woman's brain. Maturitas 2007, 57:23-26.
78. Nagel I.E., Chicherio C., Li S., von Oertzen T., Sander T., Villringer A., et al. Human aging magnifies genetic effects on executive functioning and working memory. Front Hum Neurosci 2008, 2:1.
79. Nolan K.A., Bilder R.M., Lachman H.M., Volavka J. Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am J Psychiatry 2004, 161:359-361.
80. Palmatier M.A., Kang A.M., Kidd K.K. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 1999, 46:557-567.
81. Papaleo F., Crawley J.N., Song J., Lipska B.K., Pickel J., Weinberger D.R., et al. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci 2008, 28:8709-8723.
82. Passingham R. Delayed matching after selective prefrontal lesions in monkeys (Macaca mulatta). Brain Res 1975, 92:89-102.
83. Robbins T.W. Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp Brain Res 2000, 133:130-138.
84. Rujescu D., Giegling I., Gietl A., Hartmann A.M., Möller H.J. A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biol Psychiatry 2003, 54:34-39.
85. Sabb F.W., Bearden C.E., Glahn D.C., Parker D.S., Freimer N., Bilder R.M. A collaborative knowledge base for cognitive phenomics. Mol Psychiatry 2008, 13:350-360.
86. Savitz J., Solms M., Ramesar R. The molecular genetics of cognition: dopamine COMT and BDNF. Genes Brain Behav 2006, 5:311-328.
87. Sawaguchi T., Matsumura M., Kubota K. Dopamine enhances the neuronal activity of spatial short-term memory task in the primate prefrontal cortex. Neurosci Res 1988, 5:465-473.
88. Schacter D.L., Wagner A.D. Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval. Hippocampus 1999, 9:7-24.
89. Schott B.H., Seidenbecher C.I., Fenker D.B., Lauer C.J., Bunzeck N., Bernstein H.G., et al. The dopaminergic midbrain participates in human episodic memory formation: evidence from genetic imaging. J Neurosci 2006, 26:1407-1417.
90. Seamans J.K., Gorelova N., Durstewitz D., Yang C.R. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 2001, 21:3628-3638.
91. Seamans J.K., Yang C.R. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004, 74:1-58.
92. Servan-Schreiber D., Printz H., Cohen J.D. A network model of catecholamine effects: gain signal-to-noise ratio, and behavior. Science 1990, 249:892-895.
93. Shifman S., Bronstein M., Sternfeld M., Pisanté-Shalom A., Lev-Lehman E., Weizman A., et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Med Genet 2002, 71:1296-1302.
94. Smith E.E., Jonides J. Storage and executive processes in the frontal lobes. Science 1999, 283:1657-1661.
95. Smolka M.N., Schumann G., Wrase J., Grusser S.M., Flor H., Mann K., et al. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 2005, 25:836-842.
96. Stefanis N.C., Van Os J., Avramopoulos D., Smyrnis N., Evdokimidis I., Hantoumi I., et al. Variation in catechol-o-methyltransferase val158 met genotype associated with schizotypy but not cognition: a population study in 543 young men. Biol Psychiatry 2004, 56:510-515.
97. Stefanis N.C., van Os J., Avramopoulos D., Smyrnis N., Evdokimidis I., Stefanis C.N. Effect of COMT Val158Met polymorphism on the Continuous Performance Test Identical Pairs Version: tuning rather than improving performance. Am J Psychiatry 2005, 162:1752-1754.
98. Stein D.J., Newman T.K., Savitz J., Ramesar R. Warriors versus worriers: the role of COMT gene variants. CNS Spectr 2006, 11:745-748.
99. Stein M.B., Fallin M.D., Schork N.J., Gelernter J. COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology 2005, 30:2092-2102.
100. Strauss J., Barr C.L., George C.J., Ryan C.M., King N., Shaikh S., et al. BDNF and COMT polymorphisms: relation to memory phenotypes in young adults with childhood-onset mood disorder. Neuromol Med 2004, 5:181-192.
101. Tan E.K., Khajavi M., Thornby J.I., Nagamitsu S., Jankovic J., Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology 2000, 55:533-538.
102. Tan H.Y., Callicott J.H., Weinberger D.R. Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer?. Mol Psychiatry 2008, 13:233-238.
103. Tan H.Y., Chen Q., Goldberg T.E., Mattay V.S., Meyer-Lindenberg A., Weinberger D.R., et al. Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory. J Neurosci 2007, 27:13393-13401.
104. Tan H.Y., Chen Q., Sust S., Buckholtz J.W., Meyers J.D., Egan M.F., et al. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc Natl Acad Sci U S A 2007, 104:12536-12541.
105. Tan H.Y., Sust S., Buckholtz J.W., Mattay V.S., Meyer-Lindenberg A., Egan M.F., et al. Dysfunctional prefrontal regional specialization and compensation in schizophrenia. Am J Psychiatry 2006, 163:1969-1977.
106. Tsai S.J., Hong C.J., Yu Y.W., Chen T.J. Association study of catechol-O-methyltransferase gene and dopamine D4 receptor gene polymorphisms and personality traits in healthy young Chinese females. Neuropsychobiology 2004, 50:153-156.
107. Tsai S.J., Yu Y.W., Chen T.J., Chen J.Y., Liou Y.J., Chen M.C., et al. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci Lett 2003, 338:123-126.
108. Tunbridge E.M., Bannerman D.M., Sharp T., Harrison P.J. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 2004, 24:5331-5335.
109. Tunbridge E.M., Harrison P.J., Weinberger D.R. Catechol-o-methyltransferase cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 2006, 60:141-151.
110. Tunbridge E.M., Weickert C.S., Kleinman J.E., Herman M.M., Chen J., Kolachana B.S., et al. Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb Cortex 2007, 17:1206-1212.
111. Ungerleider L.G., Courtney S.M., Haxby J.V. A neural system for human visual working memory. Proc Natl Acad Sci U S A 1998, 95:883-890.
112. Vijayraghavan S., Wang M., Birnbaum S.G., Williams G.V., Arnsten A.F. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 2007, 10:376-384.
113. Volavka J., Kennedy J.L., Ni X., Czobor P., Nolan K., Sheitman B., et al. COMT158 polymorphism and hostility. Am J Med Genet B Neuropsychiatr Genet 2004, 127B:28-29.
114. Weickert T.W., Goldberg T.E., Mishara A., Apud J.A., Kolachana B.S., Egan M.F., et al. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biol Psychiatry 2004, 56:677-682.
115. Weinberger D.R., Berman K.F., Zec R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 1986, 43:114-124.
116. Weinshilboum R.M., Otterness D.M., Szumlanski C.L. Methylation pharmacogenetics: catechol O-methyltransferase thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 1999, 39:19-52.
117. Williams-Gray C.H., Hampshire A., Barker R.A., Owen A.M. Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype. Brain 2008, 131:397-408.
118. Williams-Gray C.H., Hampshire A., Robbins T.W., Owen A.M., Barker R.A. Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J Neurosci 2007, 27:4832-4838.
119. Williams B.R., Hultsch D.F., Strauss E.H., Hunter M.A., Tannock R. Inconsistency in reaction time across the life span. Neuropsychology 2005, 19:88-96.
120. Williams G.V., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995, 376:572-575.
121. Winterer G., Coppola R., Goldberg T.E., Egan M.F., Jones D.W., Sanchez C.E., et al. Prefrontal broadband noise working memory, and genetic risk for schizophrenia. Am J Psychiatry 2004, 161:490-500.
122. Winterer G., Egan M.F., Kolachana B.S., Goldberg T.E., Coppola R., Weinberger D.R. Prefrontal electrophysiologic "noise" and catechol-O-methyltransferase genotype in schizophrenia. Biol Psychiatry 2006, 60:578-584.
123. Winterer G., Musso F., Beckmann C., Mattay V., Egan M.F., Jones D.W., et al. Instability of prefrontal signal processing in schizophrenia. Am J Psychiatry 2006, 163:1960-1968.
124. Winterer G., Musso F., Vucurevic G., Stoeter P., Konrad A., Seker B., et al. COMT genotype predicts BOLD signal and noise characteristics in prefrontal circuits. Neuroimage 2006, 32:1722-1732.
125. Winterer G., Weinberger D.R. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 2004, 27:683-690.
126. Winterer G., Ziller M., Dorn H., Frick K., Mulert C., Dahhan N., et al. Cortical activation signal-to-noise ratio and stochastic resonance during information processing in man. Clin Neurophysiol 1999, 110:1193-1203.
127. Winterer G., Ziller M., Dorn H., Frick K., Mulert C., Wuebben Y., et al. Schizophrenia: reduced signal-to-noise ratio and impaired phase-locking during information processing. Clin Neurophysiol 2000, 111:837-849.
128. Woodward N.D., Jayathilake K., Meltzer H.Y. COMT val108/158met genotype cognitive function, and cognitive improvement with clozapine in schizophrenia. Schizophr Res 2007, 90:86-96.
129. Yavich L., Forsberg M.M., Karayiorgou M., Gogos J.A., Mannisto P.T. Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci 2007, 27:10196-10209.